Senior Director, Commercial Strategy & Market Intelligence

City of Hope is a transformative organization changing lives in the fight against cancer and other illnesses. The Senior Director, Commercial Strategy & Market Intelligence will lead the development of market insights and competitive intelligence to inform strategic decisions and guide enterprise strategy.

Responsibilities:

• Lead development of market intelligence and competitive landscape assessments across key therapeutic and technology areas
• Evaluate market size, growth trends, unmet need, and commercialization dynamics to inform strategic decisions
• Develop competitive insights across biotech, pharma, academic institutions, and emerging technology players
• Monitor external trends including partnerships, M&A, venture funding, and pipeline developments
• Build analytical models including TAM/SAM/SOM, revenue forecasts, and opportunity assessments
• Create executive-ready presentations, dashboards, and strategic market insights
• Partner with cross-functional stakeholders to evaluate commercial potential and institutional fit
• Identify strategic whitespace opportunities for new capabilities, partnerships, or ventures
• Support development of business cases aligned to research and commercialization priorities
• Establish scalable frameworks, templates, and processes for market intelligence and strategy

Requirements:

• Master's degree required
• 8–12+ years of experience in life sciences strategy, market intelligence, commercial strategy, consulting, or related fields
• Proven experience building market assessments, competitive analyses, and revenue models
• Strong analytical, financial evaluation, and strategic thinking skills
• Exceptional communication and executive presentation capabilities
• Ability to translate complex scientific and clinical data into clear, actionable insights
• Demonstrated success working in cross-functional, matrixed environments
• advanced degree (MBA, PhD, MD, PharmD, MPH) strongly preferred
• Experience in oncology, precision medicine, biologics, diagnostics, AI-enabled technologies, or related sectors preferred